Viewing Study NCT02935361


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-05-30 @ 12:22 PM
Study NCT ID: NCT02935361
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-30
First Post: 2016-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelomonocytic Leukemia View
None Myelodysplastic Syndrome View
None Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes View
Keywords: